Equillium, Inc. Recorded Big Gain

Equillium, Inc. (EQ:NASDAQ) shot up at $0.89, representing a gain of 78.9%. On Mon, Aug 11, 2025, EQ:NASDAQ hit a New 2-Week High of $0.89. The stock appeared on our News Catalysts scanner on Sat, Aug 09, 2025 at 01:05 AM in the 'BIOTECH' category. From Mon, Jul 28, 2025, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Fri, Aug 01, 2025 at $1.36 with a volume of 144M+.

About Equillium, Inc. (EQ:NASDAQ)

Equillium Inc is a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is EQ001, which is a clinical stage first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in effector T cell activity, which drives a number of immuno-inflammatory diseases such as graft versus host disease, asthma, uveitis, colitis, lupus and multiple sclerosis.